Depreciation of ACADIA PHARMACEUTICALS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ACADIA PHARMACEUTICALS INC annual and quarterly Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • ACADIA PHARMACEUTICALS INC Depreciation for the quarter ending 31 Mar 2025 was $229,000, a 5.4% decline year-over-year.
  • ACADIA PHARMACEUTICALS INC annual Depreciation for 2025 was $871,000, a 5.3% decline from 2024.
  • ACADIA PHARMACEUTICALS INC annual Depreciation for 2024 was $920,000, a 37% decline from 2023.
  • ACADIA PHARMACEUTICALS INC annual Depreciation for 2023 was $1,459,000, a 28% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

ACADIA PHARMACEUTICALS INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $871,000 -$49,000 -5.3% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $920,000 -$539,000 -37% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $1,459,000 -$567,000 -28% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $2,026,000 -$210,000 -9.4% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $2,236,000 +$781,000 +54% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $1,455,000 +$166,000 +13% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $1,289,000 -$240,000 -16% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $1,529,000 +$293,000 +24% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $1,236,000 +$393,000 +47% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $843,000 +$196,000 +30% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $647,000 +$441,000 +214% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $206,000 +$127,000 +161% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $79,000 -$30,000 -28% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $109,000 -$176,000 -62% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2013 2012 FY
2011 $285,000 -$322,000 -53% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2013 2012 FY
2010 $607,000 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013 2012 FY

ACADIA PHARMACEUTICALS INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $229,000 -$13,000 -5.4% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $242,000 -$184,000 -43% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $426,000 -$90,000 -17% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $516,000 -$9,000 -1.7% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $525,000 +$231,000 +79% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $294,000 -$121,000 -29% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $415,000 +$23,000 +5.9% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $392,000 +$122,000 +45% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $270,000 +$132,000 +96% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $138,000 +$16,000 +13% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $122,000 +$79,000 +184% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $43,000 +$31,000 +258% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $12,000 -$18,000 -60% 01 Jan 2013 31 Mar 2013 10-Q 06 May 2014 2014 Q1
Q1 2012 $30,000 -$159,000 -84% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q1 2011 $189,000 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.